Albemarle (ALB) Cost of Revenue (2009 - 2026)

Albemarle has reported Cost of Revenue for 18 years, with the latest figure at $927.8 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue rose 0.78% year-over-year to $927.8 million; the trailing twelve-month figure through Mar 2026 stood at $4.5 billion (down 8.8% YoY), and the FY2025 full-year result was $4.5 billion, down 15.82% from the prior year.
• Cost of Revenue for Q1 2026 stood at $927.8 million, down from $1.2 billion in the prior quarter.
• The five-year high for Cost of Revenue was $3.1 billion in Q4 2023, with the low at $678.7 million in Q1 2022.
• Historically, Cost of Revenue has averaged $1.4 billion across 5 years, with a median of $1.2 billion in 2025.
• Annual changes were most pronounced in 2022 — Cost of Revenue surged 146.29% — and 2024, when it slumped 64.27%.
• Albemarle's Cost of Revenue stood at $1.6 billion in 2022, then surged by 88.94% to $3.1 billion in 2023, then tumbled by 64.27% to $1.1 billion in 2024, then advanced by 12.49% to $1.2 billion in 2025, then declined by 24.58% to $927.8 million in 2026.
• The last three Cost of Revenue figures came in at $927.8 million (Q1 2026), $1.2 billion (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.